Literature DB >> 4031938

Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.

S Jegou, F Javoy-Agid, C Delbende, M Ruberg, H Vaudry, Y Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4031938      PMCID： PMC1028461          DOI： 10.1136/jnnp.48.8.842

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Dementia in Parkinson's disease.

Authors:  R J Marttila; U K Rinne
Journal:  Acta Neurol Scand       Date:  1976-11       Impact factor: 3.209

2.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

3.  Dementia in Parkinson disease: a neuropathologic study.

Authors:  A M Hakim; G Mathieson
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

4.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

Authors:  M Ruberg; A Ploska; F Javoy-Agid; Y Agid
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

5.  A subcortico-cortical cholinergic system is affected in Parkinson's disease.

Authors:  B Dubois; M Ruberg; F Javoy-Agid; A Ploska; Y Agid
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

6.  Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease.

Authors:  P C Emson; J Fahrenkrug; E G Spokes
Journal:  Brain Res       Date:  1979-09-07       Impact factor: 3.252

7.  Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP.

Authors:  F Leboulenger; P Leroux; C Delarue; M C Tonon; Y Charnay; P M Dubois; D H Coy; H Vaudry
Journal:  Life Sci       Date:  1983-01-24       Impact factor: 5.037

8.  Somatostatin and dementia in Parkinson's disease.

Authors:  J Epelbaum; M Ruberg; E Moyse; F Javoy-Agid; B Dubois; Y Agid
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

9.  Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

Authors:  M Rossor; J Fahrenkrug; P Emson; C Mountjoy; L Iversen; M Roth
Journal:  Brain Res       Date:  1980-11-10       Impact factor: 3.252
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.